Results 211 to 220 of about 85,149 (286)

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

British Journal of Pharmacology, EarlyView.
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander, Dasha Anderson, Luke Baxter, Matthew Claydon, James Rucker, Emma S. J. Robinson   +5 more
wiley   +1 more source

‘Paper care not patient care’: Nurse and patient experiences of comprehensive risk assessment and care plan documentation in hospital

Journal of Clinical Nursing, Volume 32, Issue 3-4, Page 523-538, February 2023., 2023
Abstract Aims and Objectives To explore organisation‐wide experiences of person‐centred care and risk assessment practices using existing healthcare organisation documentation. Background There is increasing emphasis on multidimensional risk assessments during hospital admission. However, little is known about how nurses use multidimensional assessment
Catherine Paterson, Cara Roberts, Kasia Bail   +2 more
wiley   +1 more source

(2R,6R)‐hydroxynorketamine prevents opioid abstinence‐related negative affect and stress‐induced reinstatement in mice

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Opioid use disorder (OUD) is a pressing public health concern marked by frequent relapse during periods of abstinence, perpetuated by negative affective states. Classical antidepressants or the currently prescribed opioid pharmacotherapies have limited efficacy to reverse the negative affect or prevent relapse ...
Andria Michael, Anna Onisiforou, Polymnia Georgiou, Morfeas Koumas, Chris Powels, Elmar Mammadov, Andrea N. Georgiou, Panos Zanos   +7 more
wiley   +1 more source

Complexities in consultations in case of euthanasia or physician-assisted suicide: a survey among SCEN physicians. [PDF]

BMC Fam Pract, 2020
Bergman TD, Pasman HRW, Onwuteaka-Philipsen BD.   +2 more
europepmc   +1 more source

Medical Aid in Dying: Europe’s Urgent Medico-Ethical Challenge

International Journal of Public Health, 2023
Uwe Güth, Uwe Güth, Shaun McMillan, Edouard Battegay, Edouard Battegay, Edouard Battegay   +5 more
doaj   +1 more source

Death Talk: The Case against Euthanasia and Physician-Assisted Suicide, by Margaret Somerville

, 2002
Sarah J. Roebuck
openalex   +2 more sources

Physician-assisted suicide—a clean bill of health? [PDF]

, 2017
Robert Preston
openalex   +1 more source

The Physician-Assisted Suicide Pathway in Italy: Ethical Assessment and Safeguard Approaches. [PDF]

J Bioeth Inq
Riva L.
europepmc   +1 more source

Safety and effectiveness of fingolimod in Japanese patients with multiple sclerosis: Results of a post‐marketing surveillance study

Clinical and Experimental Neuroimmunology, EarlyView.
Abstract Objective Fingolimod is the first oral sphingosine‐1‐phosphate receptor modulator approved in Japan for multiple sclerosis (MS). A large Japanese observational study of fingolimod in patients with MS was carried out to support its safety and effectiveness in a real‐world setting.
Noriko Sato, Koji Wakimoto, Kyoko Kato, Yutaka Susuta, Kengo Ueda, Yoshihisa Satou, Takayoshi Sasajima, Jun‐ichi Kira   +7 more
wiley   +1 more source

Physicians' views on the role of relatives in euthanasia and physician-assisted suicide decision-making: a mixed-methods study among physicians in the Netherlands. [PDF]

BMC Med Ethics
Renckens SC, Onwuteaka-Philipsen BD, van der Heide A, Pasman HR.   +3 more
europepmc   +1 more source